Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2000 | 09-2000 | 06-2000 | 03-2000 | 12-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 401,052 | 96,850 | 111,980 | 89,040 | 61,400 |
| Marketable Securities | 180,286 | 178,120 | 162,270 | 176,120 | 184,880 |
| Receivables | 43,450 | 1,610 | 1,530 | 140 | 1,310 |
| Inventories | N/A | 210 | 770 | 1,260 | 23,650 |
| Other current assets | 0 | 42,130 | 37,020 | 28,020 | 7,270 |
| TOTAL | $631,258 | $318,920 | $313,570 | $294,580 | $278,510 |
| Non-Current Assets | |||||
| PPE Net | 47,514 | N/A | N/A | 45,230 | N/A |
| Investments And Advances | 169,188 | 17,900 | 13,120 | 9,070 | 7,730 |
| Other Non-Current Assets | 8,446 | 0 | 0 | 0 | 0 |
| TOTAL | $225,148 | $17,900 | $13,120 | $54,300 | $7,730 |
| Total Assets | $856,406 | $382,630 | $352,130 | $327,260 | $307,070 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 0 | 1,270 | 0 | 0 |
| Accounts payable and accrued liabilities | 1,737 | 2,030 | 1,430 | 1,210 | 1,260 |
| Accrued Expenses | 16,071 | 15,870 | 12,230 | 13,350 | 12,830 |
| Other current liabilities | N/A | 1,320 | 4,360 | 3,000 | 0 |
| TOTAL | $23,045 | $20,370 | $19,310 | $18,980 | $15,610 |
| Non-Current Liabilities | |||||
| Long Term Debt | 128,888 | 127,190 | 125,660 | 124,200 | 122,910 |
| Deferred Revenues | 4,494 | N/A | N/A | N/A | N/A |
| aiOther Non-Current Liabilities | 1,482 | 0 | 0 | 0 | 0 |
| TOTAL | $138,742 | $136,760 | $135,050 | $133,070 | $131,480 |
| Total Liabilities | $161,787 | $157,140 | $154,370 | $152,050 | $147,090 |
| Shareholders' Equity | |||||
| Common Shares | 73 | 20 | 20 | 20 | 20 |
| Retained earnings | 13,427 | -1,740 | -17,790 | -31,110 | -34,710 |
| Other shareholders' equity | 517 | -60 | -440 | -520 | -550 |
| TOTAL | $694,619 | $225,480 | $197,760 | $175,210 | $159,970 |
| Total Liabilities And Equity | $856,406 | $382,620 | $352,130 | $327,260 | $307,060 |